Optimism vs. Pessimism: The Glass Half Full Is Larger | Managed Healthcare Executive® State of the Industry Survey
Thirty-seven percent of the respondents rated themselves as optimistic about the near-term future of U.S. healthcare.
Optimism about the near future of U.S. healthcare outpaced pessimism in the Managed Healthcare Executive® annual State of the Industry survey. But it wasn’t by the largest of margins.
Thirty-seven percent of the 450 respondents to the survey rated themselves as optimistic about the near-term future of U.S. health, although the milder “somewhat optimistic” group (23%) was larger than the very optimistic group (14%). Twenty-four percent were on pessimistic, 19% classifying themselves as somewhat pessimistic and just 5% rating themselves as very pessimistic.The largest group (39%0 occupied a middle ground and rated themselves as neutral.
FDA Approves First At-Home Cervical Cancer Screening Device
May 15th 2025Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in the Department of Health Outcomes & Biomedical Informatics at the University of Florida College of Medicine.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
The First Financial Toxicity Tumor Board Reports Success in Individual Patient Savings
May 14th 2025Financial toxicity can affect patient outcomes and quality of life. For example, a patient may forgo treatment or medications to save money, or they may incur high medical debt or go into bankruptcy to pay for medical care.
Read More
